Drug developers can identify new opportunities and get insight into their failures when they mine their in-house clinical trial data. But to gain maximum insight, companies would do well to pool and share their data sets, argues Charles Hugh-Jones, Chief Medical Officer in North America at Sanofi. To this end, he and his collaborators from the CEO Roundtable on Cancer are preparing to launch Project Data Sphere, a non-profit platform designed to share the comparator arm data from dozens of cancer clinical trials. Hugh-Jones talks to Asher Mullard about the need for, and the promise of, data sharing.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Rights and permissions
About this article
Cite this article
Charles Hugh-Jones. Nat Rev Drug Discov 12, 900 (2013). https://doi.org/10.1038/nrd4190
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd4190
